Brief: InDex Pharmaceuticals' Rights Issue Is Oversubscribed

Flerie AB

09/02/2021 09:25

Feb 9 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS' RIGHTS ISSUE IS OVERSUBSCRIBED
    * INDEX WILL, THROUGH RIGHTS ISSUE, RECEIVE APPROXIMATELY
SEK 533
MILLION BEFORE DEDUCTION OF COSTS RELATED TO TRANSACTION.
    * SUBSCRIPTION RATIO IN RIGHTS ISSUE AMOUNTED TO 152.6
PERCENT.
    * THROUGH RIGHTS ISSUE, COMPANY WILL RECEIVE APPROXIMATELY
SEK 533
MILLION BEFORE DEDUCTION OF COSTS

Source text for Eikon:  ID:nWkrhKpsd 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))